Lupus nephritis: Benlysta (belimumab), Lupkynis (voclosporin)
High cholesterol: Leqvio (inclisiran), Nexletol (bempedoic acid), Nexlizet (bempedoic acid/ezetimibe)
Multiple myeloma: Abecma (idecabtagene vicleucel), Carvykti (ciltacabtagene autoleucel)
Atopic dermatitis: Adbry (tralokinumab), Cibinqo (abrocitinib), Opzelura (ruxolitinib), Rinvoq (upadacitinib)
Hypertrophic cardiomyopathy: Camyzos (mavacamten)
Hereditary angioedema: Cinryze (C1 esterase inhibitor), Haegarda (C1 esterase inhibitor), Tahkzyro (lanadelumab)
Asthma: Tezspire (tezepelumab)
Myasthenia gravis: Soliris (eculizumab), Vyvgart (efgartigimod)

Health Plan Transparency Still At Issue, ICER Finds

More from Drug Pricing